Evaluation of the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease (the RAINIER Study)
NCT03633461
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
53
Enrollment
INDUSTRY
Sponsor class
Conditions
Dry Eye Disease
Interventions
DRUG:
OC-02 (simpinicline) nasal spray
DRUG:
Placebo (vehicle) nasal spray
Sponsor
Oyster Point Pharma, Inc.